Coherus Biosciences | Zinsaufwendungen Für Schuld



Interest Expense On Debt Veränderung Datum
AbbVie USD 610M 19M 2024-12
Acadia Pharmaceuticals 0 4.12M 2024-09
ALKERMES USD 0 4.65M 2025-03
Alnylam Pharmaceuticals USD 38.65M 325K 2025-03
Amarin USD 3K 3K 2024-12
Amgen USD 723M 24M 2025-03
Baxter International USD 100M 1000K 2024-12
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.86M 286K 2025-03
Bristol-Myers Squibb USD 494M 2M 2025-03
Eli Lilly USD 243.7M 19M 2025-03
Fujifilm JPY 2.61B 743M 2025-03
Gilead Sciences USD 260M 12M 2025-03
Ironwood Pharmaceuticals USD 8.74M 506K 2024-12
Merck USD 313M 15M 2025-03
Myriad Genetics USD 800K 100K 2025-03
Pacira USD 3.71M 967K 2025-03
Perrigo 39M 4.1M 2025-03
Pfizer USD 654M 85M 2025-03
PTC Therapeutics USD 43.35M 1.24M 2024-12
Regeneron Pharmaceuticals USD 8.7M 1.8M 2025-03
Sarepta Therapeutics USD 4.92M 86K 2024-09
Teva Pharmaceutical Industries USD 212M 12M 2025-03
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12
Xencor 8.66M 48.02M 2025-03
Zoetis USD 54M 3M 2025-03



Coherus Biosciences Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.